1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Page title and breadcrumb confirm 'Merck Group: research grants - Preliminary proposals' exists on the Technion R&D Foundation site; rendered body content was not extractable but the page structure is present.
Research Grants (Neuroinflammatory Diseases, AI in Cell Culture, Contaminated Materials, Cell-free Screening, Molecule Synthesis) is a grant from Merck Group that funds scientific research in five focus areas for 2026: in-vitro models for neuroinflammatory disease therapies, AI-assisted cell culture optimization, contaminated materials testing, cell-free screening platforms, and small molecule synthesis.
Awards provide up to 500,000 euros per year for up to three years, with specific amounts varying by grant area. Scientists at all career stages affiliated with research institutions, universities, or companies are eligible to apply. The deadline for preliminary proposals is August 31, 2026.
Get alerted about grants like this
Save a search for “Merck Group” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Merck Group: research grants - Preliminary proposals | Technion R&D Foundation Ltd Preventing sexual harassment Technion Executive vice President for Research Materials Manufacturing Technologies Calls For Proposals Horizon Europe Preventing sexual harassment Technion Executive vice President for Research Merck Group: research grants – Preliminary proposals Merck Group: research grants – Preliminary proposals Preventing sexual harassment Technion Executive vice President for Research Merck Group: research grants – Preliminary proposals In 2026, grants are available in the following areas: In-vitro models and assays to identify novel therapies for neuroinflammatory diseases.
To develop predictive in-vitro models aimed at identifying and optimizing novel small molecule medicines for human neuroinflammatory diseases. One grant of up to 500K EUR over 2 years. Artificial intelligence in cell culture media and process development.
Proposals for robust, host-agnostic, and easy to parameterize models, that enable us to more quickly develop fit-for-purpose solutions for the optimization of bioprocesses for a broad base of host organisms. One grant of up to 150K EUR/year for up to 3 years. Innovative approaches to economical remediation of contaminated high volume materials.
Proposals dedicated to the remediation of high-volume, low-contaminated soil and water, with a specific focus on chloro-organic pollutants and particularly those contaminated with hexachlorocyclohexane (HCH). One grant of up to 150K EUR/year for up to 2 years. Condensate-based high-sensitivity cell-free screening assays for the modulation of protein-protein interactions.
One grant of up to 100K EUR/year for up to 3 years. Advancing molecule synthesis and discovery – up to 3 grants each comprising a 1-year full Synthia® Retrosynthesis Software license, training, and extensive interaction with our scientists. www.
merckgroup. com/en/research/open-innovation/research-grants. html
According to the current listing, eligibility includes: Scientists in all career stages affiliated with any research-based institution, university, or company. Confirm the full requirements in the official notice before applying.
The current listing shows up to 500,000 € per year for up to 3 years (specific amounts vary by grant area). Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Research Grants (Neuroinflammatory Diseases, AI in Cell Culture, Contaminated Materials, Cell-free Screening, Molecule Synthesis) are due August 31, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Research Grants (Neuroinflammatory Diseases, AI in Cell Culture, Contaminated Materials, Cell-free Screening, Molecule Synthesis) is funded by Merck Group. Verify program details on the funder's official page before applying.
This listing is flagged as international in scope. Check the official notice for country-specific restrictions before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.